Top Considerations in Pediatric Cancer Treatment: What Payers Should Know
A Stanford expert describes ideal treatment locations, common barriers, and how payers could better support patients and families.
Read More
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be Close
In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
Healthcare Data Breaches: 4 Tips for Healthcare Execs
A University of Phoenix College of Health Professions survey has surprising findings about RNs and health administrator views on healthcare hacking.
Four Best Practices to Help Prevent Healthcare Cyberattacks
A new report from Radware has shocking findings about the healthcare industry’s low preparedness levels for cyberthreats. Here’s 4 ways to get ready.
All Healthcare is not Local The Human Cost of Disparate Health Data
How a customized COPD care bundle is reducing readmissions
Reducing readmissions for chronic obstructive pulmonary disease (COPD) is an ongoing challenge for healthcare systems. Here’s how one is successful.
How the Flu’s Severity Will Affect Healthcare Spending
The flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
Pfizer VP Robert Popovian Talks Value-Based Reimbursement
The impact of VBRs on outcomes, VBRs versus other healthcare reimbursement initiatives, and VBR successes and failures. Pfizer’s Robert Popovian, PharmD, weighs in.
Blindness gene therapy price tag stirs controversy
A patient advocacy group is criticizing the hefty price tag of a new treatment for blindness.
Four pain management programs curbing the opioid epidemic
From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy Changes
How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.
Survey uncovers lupus corticosteroid treatment issues
Patients with systemic lupus erythematosus often self-manage their corticosteroid medication without the consent of their healthcare providers, according to a recent multicountry survey.
Five factors driving up the cost of oncology drugs
The high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
Four reasons COPD patients don’t receive the right treatments
Many providers are overlooking important steps that can help guide proper COPD treatment and therefore, reduce admissions and readmissions.
Six things to know about CMS' new bundled payment model
CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Despite hype, private payers slow to adopt oncology value-based models
Oncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic predictions.
Four things to know about your millennial workforce
How actively engaging millennials can help manage healthcare staffing challenges.
Trump’s impact on ACA enrollment: What you need to know
How did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.
Four COPD treatment changes to watch
Pending and recently approved treatment options for patients with chronic obstructive pulmonary disease range from biologics to a triple-drug inhaler.
FDA takes tough stance on kids’ opioid cold meds
FDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
FDA approves first drug for breast cancer with BRCA gene
FDA approved the first drug to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation.
How health execs can partner with pharmacists to address opioids
Director of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
Most employees unsatisfied with employers' well-being programs
Willis Towers Watson research finds a dramatic increase among employers seeking to differentiate their health and well-being programs for competitive advantage.
Lessons learned from program to improve healthcare information exchange
One major piece of interoperability is the expanded use of admission, discharge, and transfer (ADT) notifications across provider networks.
Three ways healthcare executives can uncover consumers at risk for flu
With influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
CAR T-cell therapies in treating lymphoma: Pros and cons
Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Four of the biggest challenges faced by health information organizations
Four health information organizations recently convened to discuss their challenges and successes in interoperability stability and infrastructure.
Three ways to combat sexual harassment in healthcare organizations
More reports of sexual harassment in the workplace are arising every day. It’s time to rethink your prevention strategies.
Expansion of association health plans: 6 things to know about Trump’s proposal
Trump’s new proposal would broaden access to association health plans. Here’s six things to know.
Drug shortage help on horizon
While hospitals continue to face IV saline shortages after two hurricanes significantly damaged infrastructure in Puerto Rico, the situation should improve early this year.
